iPSCs Manufacturing Services Market Size is valued at USD 1.3 billion in 2024 and is predicted to reach USD 4.6 billion by the year 2034 at a 14.1 % CAGR during the forecast period for 2025-2034. Induced Pluripotent Stem Cells (iPSC) are originated from skin or blood cells. iPSCs are cells that are reprogrammed from somatic cells using different transcription factors. These cells are pluripotent, have the potential for...
Report ID: 1223 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
The Patient Recruitment and Retention Services Market Size is valued at USD 4.1 Billion in 2024 and is predicted to reach USD 6.7 Billion by the year 2034 at a 5.3% CAGR during the forecast period for 2025-2034. Patient recruitment and retention is an essential service for the clinical research industry, and certain developments are expected to play a significant role in the future. Patient recruitment is one of the r...
Report ID: 1335 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 190
The Nuclear Pharmacy Market Size is valued at USD 6.27 Bn in 2024 and is predicted to reach USD 17.96 Bn by the year 2034 at a 11.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The market is growing because technological developments have made it possible to diagnose and treat malignant tumours with radiopharmaceuticals. Rising government financing for nuclear medic...
Report ID: 1980 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 180
Vaccine Contract Manufacturing Market Size is valued at USD 2.3 Bn in 2024 and is predicted to reach USD 3.9 Bn by the year 2034 at a 6.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The vaccine contract manufacturing market is experiencing significant growth driven by increasing demand for vaccines globally, Asia-Pacific is anticipated to exhibit the most r...
Report ID: 2303 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 179
Gene Therapy Market Size is valued at USD 2.4 Bn in 2024 and is predicted to reach USD 13.6 Bn by the year 2034 at a 19.05% CAGR during the forecast period for 2025-2034 Gene therapy is a therapeutic approach that targets the fundamental genetic problem in order to treat or prevent diseases. Gene therapy offers an alternative to medications or surgery, enabling doctors to address a condition by modifying an individual's ge...
Report ID: 2215 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 179
The Biopharmaceutical Excipient Manufacturing Market Size is valued at 2.73 Billion in 2024 and is predicted to reach 4.38 Billion by the year 2034 at a 5.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Increasing need for generic drugs and pharmaceutical products is driving the biopharmaceutical excipient manufacturing market. Technological advancements in bioprocessin...
Report ID: 1197 |
Delivery: Immediate |
Published: March 2025 |
No. of Pages: 190
Ischemic Heart Disease (IHD) Drugs Market Size was valued at USD 6.07 Bn in 2023 and is predicted to reach USD 8.46 Bn by 2031 at a 4.4% CAGR during the forecast period for 2024-2031. Ischemic heart disease (IHD) drugs are those that treat situations where the heart does not receive enough blood, most often because the coronary arteries are too small or too clogged. Some of these medications can alleviate chest pain, lower cholesterol, reduce ...
Report ID: 2506 |
Delivery: Immediate |
Published: February 2025 |
No. of Pages: 180
The Global Pediatric MRI Market Size is valued at USD 3.57 billion in 2022 and is predicted to reach USD 6.62 billion by the year 2031 at a 7.3% CAGR during the forecast period for 2023-2031. Key Industry Insights & Findings from the Report: There is growing awareness among healthcare professionals and parents about the importance of early diagnosis and intervention in pediatric diseases. MRI is extensively used in pediatr...
Report ID: 2043 |
Delivery: Immediate |
Published: February 2025 |
No. of Pages: 180
The Latent Tuberculosis Infection Detection Market Size is valued at USD 1.53 billion in 2023 and is predicted to reach USD 2.37 billion by the year 2031 at a 5.7% CAGR during the forecast period for 2024-2031. Latent tuberculosis infection (LTBI) detection is a critical component of tuberculosis (TB) control, aiming to prevent the progression to active TB disease. Regular screening and effective detection strategies are vital for reducing TB ...
Report ID: 2579 |
Delivery: Immediate |
Published: February 2025 |
No. of Pages: 175
The Monkeypox Vaccine And Treatment Market Size is valued at 85.86 Million in 2023 and is predicted to reach 212.34 Million by the year 2031 at an 12.39 % CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: Increase in the prevalence of monkeypox is driving the monkeypox vaccine and treatment market. Increasing in the demand for vaccines as well as new treatment for monkeypox i...
Report ID: 1394 |
Delivery: Immediate |
Published: February 2025 |
No. of Pages: 180
Pharmaceuticals